https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ANicotinamide_mononucleotide%2F3%2FenTranslations:Nicotinamide mononucleotide/3/en - Revision history2026-09-14T02:58:18ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Nicotinamide_mononucleotide/3/en&diff=136461&oldid=prevFuzzyBot: Importing a new version from external source2024-04-07T23:48:37Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>Because NADH is a [[Cofactor (biochemistry)|cofactor]] for processes inside [[mitochondria]], for [[sirtuin]]s and [[Poly (ADP-ribose) polymerase|PARP]], NMN has been studied in [[animal model]]s as a potential neuroprotective and [[anti-aging]] agent. The reversal of aging at the cellular level by inhibiting [[mitochondrial decay]] in presence of increased levels of NAD+ makes it popular among anti-aging products. Dietary supplement companies have [[Hard sell|aggressively marketed]] NMN products, claiming those benefits. However, no human studies to date have properly proven its anti-aging effects with proposed health benefits only suggested through research done [[in vitro]] or through [[Animal testing|animal models]]. Single-dose administration of up to 500 mg was shown safe in men in a study at [[Keio University]]. One 2021 clinical trial found that NMN improved muscular insulin sensitivity in prediabetic women, while another found that it improved aerobic capacity in amateur runners. A 2023 clinical trial showed that NMN improves performance on a six-minute walking test and a subjective general health assessment.</div>FuzzyBot